サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1423874

医薬品包装の世界市場：原材料別、タイプ別、ドラッグデリバリー別、地域別 - 予測（～2028年）

Pharmaceutical Packaging Market by Raw Material (Plastic, Paper & Paperboard, Glass, Metal), Type (Plastic Bottles, Blisters, Caps & Closures, Labels & Accessories, Pre-filled Syringes), Drug Delivery, and Region - Global Forecast to 2028
出版日: | 発行: MarketsandMarkets | ページ情報: 英文 299 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.52円
医薬品包装の世界市場：原材料別、タイプ別、ドラッグデリバリー別、地域別 - 予測（～2028年）
出版日: 2024年02月06日
発行: MarketsandMarkets
ページ情報: 英文 299 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の医薬品包装の市場規模は、2023年に1,320億米ドル、2028年までに2,699億米ドルに達し、CAGRで15.4％の成長が予測されています。

医薬品包装の需要の増加は医療支出の急増によって促進されており、ストリップパック、エアロゾルジェネレーター、折りたたみ式チューブ、キャニスター、インプラント、ブリスターパックなどのさまざまな包装製品が求められています。医薬品包装業界における技術の進歩は、スマート包装や無菌包装などの革新的なソリューションを生み出し、市場全体の成長に寄与しています。

調査範囲
調査対象年 2020年～2028年
標準年 2022年
予測期間 2023年～2028年
単位 米ドル
セグメント タイプ別、包装タイプ別、ドラッグデリバリー別、原材料別、地域別
対象地域 北米、アジア太平洋、欧州、中東・アフリカ、南米

「タイプ別では、ラベル・付属品が予測期間に3番目に高いCAGRを占めます。」

ラベル・付属品市場は、医薬品包装市場に牽引され大きな成長を示しています。医薬品包装におけるラベルと付属品は、医薬品の安全性、有効性、適正使用を保証する上で重要な役割を果たしています。ラベルは、用法、有効期限、成分リストなど、製品に関する重要な情報を伝える上で重要な役割を果たしています。さらに、ラベルは製品の識別と理解を助け、患者の安全性を高め、規制標準の遵守を確実にします。開封明示要素や対小児安全包装などの付属品は、製品を保護し不正アクセスを抑止するために特別に作られており、特に小児が摂取した場合や製品の完全性が損なわれた場合にリスクがある医薬品に適しています。

「包装タイプ別では、一次包装が予測期間にもっとも急成長する包装タイプです。」

一次包装は、医薬品と直接接触する最初の層であり、医薬品の品質と有効性を維持する上で重要な役割を担っています。この市場には、アンプル、バイアル、コンテナー、ストリップ包装、ブリスター包装、シリンジ、ボトル、サシェ包装など、多様な形態の包装が含まれます。ドラッグデリバリーシステムの進化に伴い、プレフィルド吸入器、シリンジ、その他の特殊なデバイスを含む新しい投与方法をサポートする革新的な一次包装ソリューションが頻繁に必要とされます。このような要因が医薬品包装市場における一次包装セグメントを牽引しています。

「ドラッグデリバリー別では、注射が予測期間に2番目に大きな市場となります。」

注射によるドラッグデリバリーは標的部位への迅速かつ効率的な送達が可能であることから、非常に効果的かつ成功率の高い薬剤投与経路として認識されています。ほとんどの薬剤は経口または注射によって投与されますが、注射には自己注射器、プレフィルドシリンジ、自動注射器、安全注射器、パッチ注射器、ペン型注射器などのさまざまな形態があります。生物製剤市場の成長も、予測期間における注射市場の拡大に寄与すると予測されます。

「原材料別では、紙・板紙が予測期間に第2位の市場シェアを占めます。」

板紙材料は、表面積が大きく製品の陳列性が向上するため、カートン、ブリスター財布、硬質箱などの医薬品二次包装に広く使用されています。表面特性、色、明るさ、不透明度、重量、木目方向、引張強度、引裂強度といった紙基材の属性は、板紙包装の生産において重要な考慮事項です。医薬品包装用の紙と板紙は、ブランディング、ラベリング、患者アドヒアランス機能、点字コンプライアンス機能、規制情報の包含といった側面に焦点を当てた将来の発展が予測されており、市場成長に寄与すると見込まれています。紙ベースの包装には視覚に訴える印刷への大きな需要があり、このセグメントの拡大をさらに促進しています。

当レポートでは、世界の医薬品包装市場について調査分析し、主な促進要因と抑制要因、競合情勢、将来の動向などの情報を提供しています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 医薬品包装市場の企業にとって魅力的な機会
  • 医薬品包装市場：タイプ別
  • 医薬品包装市場：原材料別
  • 医薬品包装市場：ドラッグデリバリー別
  • 医薬品包装市場：包装タイプ別
  • 医薬品包装市場：主要国別

第5章 市場の概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • バリューチェーン分析
    • 原材料のサプライヤー
    • 製品の研究開発
    • メーカー
    • 販売業者
    • エンドユーザー
  • ポーターのファイブフォース分析
  • マクロ経済指標
  • 関税と規制情勢
    • 規制
    • 規格
    • 規制機関、政府機関、その他の組織
  • 技術分析
    • ナノテクノロジー
    • 生物製剤包装
    • スマート包装
    • 偽造防止包装
    • その他のスマート動向、技術
  • 価格分析
    • 平均販売価格：地域別
    • 平均販売価格：原材料別
  • エコシステム/市場マップ
  • 顧客のビジネスに影響を与える動向/混乱
  • 特許分析
  • 原材料の分析
    • プラスチック
    • 紙
    • ガラス
    • 金属
  • 貿易分析
    • 輸入シナリオ
    • 輸出シナリオ
  • 主な会議とイベント（2024年～2025年）
  • ケーススタディ分析
  • 主なステークホルダーと購入標準
    • 購入プロセスにおける主なステークホルダー
    • 購入標準

第6章 医薬品包装市場：包装タイプ別

  • イントロダクション
  • 一次
  • 二次

第7章 医薬品包装市場：原材料別

  • イントロダクション
  • プラスチック
  • 紙・板紙
  • ガラス
  • 金属
  • その他の原材料

第8章 医薬品包装市場：ドラッグデリバリー別

  • イントロダクション
  • 経口
  • 肺
  • 経皮
  • 注射
  • 局所
  • 鼻腔
  • 眼科/眼科
  • 静脈
  • その他のドラッグデリバリー方式

第9章 医薬品包装市場：タイプ別

  • イントロダクション
  • ペットボトル
  • ブリスターパック
  • ラベル・付属品
  • キャップ・クロージャー
  • 医療用特殊バッグ
  • プレフィルドシリンジ
  • 温度管理包装
  • パウチ・ストリップパック
  • アンプル
  • バイアル
  • プレフィルド吸入器
  • 薬剤チューブ
  • ジャー・キャニスター
  • カートリッジ
  • その他のタイプ

第10章 医薬品包装市場：地域別

  • イントロダクション
  • 北米
    • 景気後退の影響
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 景気後退の影響
    • ドイツ
    • フランス
    • イタリア
    • 英国
    • スペイン
    • ロシア
    • その他の欧州
  • アジア太平洋
    • 景気後退の影響
    • 中国
    • 日本
    • 韓国
    • インド
    • オーストラリア
    • その他のアジア太平洋
  • 南米
    • 景気後退の影響
    • ブラジル
    • アルゼンチン
    • その他の南米
  • 中東・アフリカ
    • 景気後退の影響
    • GCC
    • 南アフリカ
    • その他の中東・アフリカ

第11章 競合情勢

  • 概要
  • 主要企業の戦略/有力企業
  • 収益分析
  • 市場シェア分析
    • 主な市場企業のランキングの分析（2022年）
    • 主要企業の市場シェア（2022年）
  • 企業の評価マトリクス
  • スタートアップ/中小企業の評価マトリクス
  • 競合シナリオと動向

第12章 企業プロファイル

  • 主要企業
    • BERRY GLOBAL INC.
    • GERRESHEIMER AG
    • AMCOR PLC
    • SCHOTT AG
    • APTARGROUP, INC.
    • BD
    • WESTROCK COMPANY
    • NIPRO CORPORATION
    • CATALENT, INC.
    • SEALED AIR
    • WEST PHARMACEUTICAL SERVICES, INC.
  • その他の企業
    • ALPLA
    • ARDAGH GROUP S.A.
    • CCL INDUSTRIES INC.
    • FRANK NOE
    • GAPLAST GMBH
    • LONZA
    • MONDI GROUP
    • NOLATO AB
    • ORIGIN PHARMA PACKAGING
    • COMAR
    • BILCARE LIMITED
    • SGD PHARMA
    • SILGAN HOLDINGS INC.
    • VETTER PHARMA INTERNATIONAL GMBH

第13章 付録

目次
Product Code: CH 3482

The market for pharmaceutical packaging is approximated to be USD 132.0 billion in 2023, and it is projected to reach USD 269.9 billion by 2028 at a CAGR of 15.4%. The increasing demand for pharmaceutical packaging is driven by the surge in healthcare expenditures, necessitating a higher requirement for various packaging products such as strip packs, aerosol generators, collapsible tubes, canisters, implants, and blister packs. Technological advancements in the pharmaceutical packaging industry have given rise to innovative solutions such as smart packaging and sterile packaging, contributing to the overall growth of the market.

Scope of the Report
Years Considered for the Study2020-2028
Base Year2022
Forecast Period2023-2028
Units ConsideredValue (USD)
SegmentsType, By Packaging Type, Drug Delivery, Raw Material, and Region
Regions coveredNorth America, APAC, Europe, Middle East & Africa, and South America

"By Type, Labels & accessories accounted for the third highest CAGR during the forecast period."

The labels & accessories market is experiencing significant growth driven by the pharmaceutical packaging market. Labels & accessories in pharmaceutical packaging play a critical role in ensuring the safety, efficacy, and proper usage of medications. Labels play a crucial role in conveying vital information about a product, encompassing dosage instructions, expiration dates, and lists of ingredients. Additionally, labels aid in the identification and comprehension of the product, enhancing patient safety and ensuring compliance with regulatory standards. Accessories such as tamper-evident elements and child-resistant packaging are specifically crafted to safeguard products and deter unauthorized access, especially for medications carrying a risk if consumed by children or if the product's integrity is compromised.

"By Packaging Type, Primary packaging is the fastest growing packaging type during the forecast period."

The primary packaging is the first and initial layer of packaging directly in contact with the drug and holds significant importance in preserving the quality and effectiveness of pharmaceutical products. This market encompasses diverse forms of packaging, including ampoules, vials, containers, strip packaging, blister packaging, syringes, bottles, and sachet packaging. The evolution of drug delivery systems frequently requires innovative primary packaging solutions to support novel administration methods, including prefilled inhalers, syringes, and other specialized devices. These factors drive the primary packaging segment in the pharmaceutical packaging market.

"By Drug Delivery, Injectables accounted for the second largest market during the forecast period."

Injectable drug delivery modes are recognized as highly effective and successful routes of drug administration due to their rapid and efficient delivery to the target area. While most drugs are administered orally or through injections, injectables come in various forms such as self-injection devices, prefilled syringes, auto-injectors, safety syringes, patch injectors, pen injectors, and more. The growth of the biologics market is also anticipated to contribute to the expansion of the injectables market in the forecast period.

"By Raw Material, Paper & paperboard accounted for the second largest market share during the forecast period."

Paperboard materials are widely used for secondary pharmaceutical packaging, such as cartons, blister wallets, and rigid boxes, due to their greater surface area and improved product display. The attributes of the paper substrate, such as surface properties, color, brightness, opacity, basis weight, grain direction, tensile strength, and tearing strength, are important considerations in the production of paperboard packaging. Anticipated future developments in paper and paperboard for pharmaceutical packaging, focusing on aspects such as branding, labeling, patient adherence functionality, braille compliance features, and the inclusion of regulatory information, are expected to contribute to market growth. There is a notable demand for visually appealing prints on paper-based packaging, further fostering the expansion of this segment.

"Europe is projected to account for the second largest market share in the pharmaceutical packaging market during the forecast period."

In Europe, there is a growing demand for primary packaging products driven by advanced drug delivery modes such as prefilled inhalers and pre-filled syringes. Additionally, caps & closures, blister packs, and specialty bags contribute to the growing demand for primary packaging in the region. The rising demand for pharmaceutical packaging in the European region is driven by the growing activities in pharmaceutical research, production, and distribution. Significant advancements in the field of medical biopharmaceuticals are further boosting the market in the region. The pharmaceutical packaging industry has witnessed consistent growth in countries such as Germany, France, and the UK, owing to their health-conscious population.

Primaries-

By Company Type: Tier 1: 25%, Tier 2: 50%, and Tier 3: 25%

By Designation: C-level Executives: 30%, Directors: 20%, and Others: 50%

By Region: North America: 20%, Europe: 30%, Asia Pacific: 25%, Latin America: 15%, and Middle East & Africa: 10%

Companies Covered: Berry Global (US), Amcor Plc (Switzerland), Gerresheimer AG (Germany), Schott AG (Germany), and AptarGroup, Inc. (US) are some of the established players in the pharmaceutical packaging market.

Research Coverage

The market study covers the pharmaceutical packaging market across various segments. It aims at estimating the market size and the growth potential of this market across different segments based on type, packaging type, raw material, drug delivery, and region. The study also includes an in-depth competitive analysis of key players in the market, their company profiles, key observations related to their products and business offerings, recent developments undertaken by them, and key growth strategies adopted by them to improve their position in the pharmaceutical packaging market.

Key Benefits of Buying the Report

The report is expected to help the market leaders/new entrants in this market share the closest approximations of the revenue numbers of the overall pharmaceutical packaging market and its segments and sub-segments. This report is projected to help stakeholders understand the competitive landscape of the market, gain insights to improve the position of their businesses and plan suitable go-to-market strategies.

The report provides insights on the following pointers:

  • Analysis of drivers (the rising demand for pharmaceutical packaging in the pharmaceutical industry), restraints (raw material cost of pharmaceutical packaging products), opportunities (growing demand for sustainable packaging), and challenges (safeguarding against counterfeit products in pharmaceutical packaging) influencing the growth of pharmaceutical packaging market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and mergers & acquisitions in the pharmaceutical packaging market.
  • Market Development: Comprehensive information about lucrative emerging markets - the report analyzes the markets for pharmaceutical packaging market across regions.
  • Market Diversification: Exhaustive information about new products % services, untapped geographies, recent developments, and investments in the pharmaceutical packaging market
  • Market Penetration: Comprehensive information on the pharmaceutical packaging market offered by top players in the global market.
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the pharmaceutical packaging

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 INCLUSIONS & EXCLUSIONS
    • TABLE 1 PHARMACEUTICAL PACKAGING MARKET: INCLUSIONS & EXCLUSIONS
  • 1.4 STUDY SCOPE
    • FIGURE 1 PHARMACEUTICAL PACKAGING MARKET SEGMENTATION
    • 1.4.1 REGIONS COVERED
    • FIGURE 2 REGIONAL SCOPE
    • 1.4.2 YEARS CONSIDERED
  • 1.5 CURRENCY CONSIDERED
  • 1.6 UNITS CONSIDERED
  • 1.7 STAKEHOLDERS
  • 1.8 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 3 PHARMACEUTICAL PACKAGING MARKET: RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key secondary sources
      • 2.1.1.2 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key primary sources
      • 2.1.2.2 Key data from primary sources
      • 2.1.2.3 Key industry insights
      • 2.1.2.4 Breakdown of primary interviews
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
    • FIGURE 4 PHARMACEUTICAL PACKAGING MARKET: BOTTOM-UP APPROACH
    • 2.2.2 TOP-DOWN APPROACH
    • FIGURE 5 PHARMACEUTICAL PACKAGING MARKET: TOP-DOWN APPROACH
  • 2.3 DATA TRIANGULATION
    • FIGURE 6 PHARMACEUTICAL PACKAGING MARKET: DATA TRIANGULATION
    • 2.3.1 PHARMACEUTICAL PACKAGING MARKET ANALYSIS THROUGH PRIMARY SOURCES
    • 2.3.2 PHARMACEUTICAL PACKAGING MARKET ANALYSIS THROUGH SECONDARY SOURCES
    • FIGURE 7 PHARMACEUTICAL PACKAGING MARKET ANALYSIS
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 FACTOR ANALYSIS
  • 2.6 GROWTH ESTIMATION
    • 2.6.1 SUPPLY SIDE
    • 2.6.2 DEMAND SIDE
  • 2.7 LIMITATIONS & RISKS
  • 2.8 RECESSION IMPACT

3 EXECUTIVE SUMMARY

    • FIGURE 8 PLASTIC BOTTLES TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD
    • FIGURE 9 PLASTICS TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD
    • FIGURE 10 ORAL DRUG DELIVERY MODE TO DOMINATE MARKET DURING FORECAST PERIOD
    • FIGURE 11 PRIMARY PACKAGING TO ACCOUNT FOR LARGER SHARE DURING FORECAST PERIOD
    • FIGURE 12 ASIA PACIFIC TO BE FASTEST-GROWING PHARMACEUTICAL PACKAGING MARKET DURING FORECAST PERIOD

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PHARMACEUTICAL PACKAGING MARKET
    • FIGURE 13 ASIA PACIFIC TO OFFER LUCRATIVE OPPORTUNITIES IN PHARMACEUTICAL PACKAGING MARKET DURING FORECAST PERIOD
  • 4.2 PHARMACEUTICAL PACKAGING MARKET, BY TYPE
    • FIGURE 14 PREFILLED SYRINGES TO RECORD FASTEST GROWTH DURING FORECAST PERIOD
  • 4.3 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL
    • FIGURE 15 PLASTICS SEGMENT TO RECORD HIGHEST CAGR DURING FORECAST PERIOD
  • 4.4 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY
    • FIGURE 16 INJECTABLES SEGMENT TO BE FASTEST-GROWING MARKET BY 2028
  • 4.5 PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE
    • FIGURE 17 PRIMARY SEGMENT TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD
  • 4.6 PHARMACEUTICAL PACKAGING MARKET, BY KEY COUNTRY
    • FIGURE 18 INDIA TO DOMINATE MARKET DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 19 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN PHARMACEUTICAL PACKAGING MARKET
    • 5.2.1 DRIVERS
      • 5.2.1.1 Surge in healthcare expenditure and growth of pharmaceutical industry
      • 5.2.1.2 Rising demand for drug delivery devices and blister packaging
      • 5.2.1.3 Technological advancements in pharmaceutical packaging
        • 5.2.1.3.1 Nanomedicine and nano drug delivery systems
        • 5.2.1.3.2 Child-resistant packaging
        • 5.2.1.3.3 Radio-frequency identification
        • 5.2.1.3.4 Micro-pump technology
        • 5.2.1.3.5 Eco-friendly and sustainable packaging
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Surge in packaging costs due to dynamic regulatory policies
      • 5.2.2.2 Restricted access to healthcare systems in emerging economies
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing demand for primary pharmaceutical packaging
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Safeguarding against counterfeit products
  • 5.3 VALUE CHAIN ANALYSIS
    • FIGURE 20 PHARMACEUTICAL PACKAGING MARKET: VALUE CHAIN ANALYSIS
    • 5.3.1 RAW MATERIAL SUPPLIERS
    • 5.3.2 R&D OF PRODUCTS
    • 5.3.3 MANUFACTURERS
    • 5.3.4 DISTRIBUTORS
    • 5.3.5 END USERS
  • 5.4 PORTER'S FIVE FORCES ANALYSIS
    • FIGURE 21 PORTER'S FIVE FORCES ANALYSIS OF PHARMACEUTICAL PACKAGING MARKET
    • 5.4.1 THREAT OF NEW ENTRANTS
    • 5.4.2 THREAT OF SUBSTITUTES
    • 5.4.3 BARGAINING POWER OF BUYERS
    • 5.4.4 BARGAINING POWER OF SUPPLIERS
    • 5.4.5 INTENSITY OF COMPETITIVE RIVALRY
    • TABLE 2 IMPACT OF PORTER'S FIVE FORCES ON PHARMACEUTICAL PACKAGING MARKET
  • 5.5 MACROECONOMIC INDICATORS
    • 5.5.1 GLOBAL GDP TRENDS
    • TABLE 3 TRENDS OF PER CAPITA GDP (USD), 2019-2021
    • TABLE 4 GDP GROWTH ESTIMATE AND PROJECTION OF KEY COUNTRIES, 2022-2027
    • TABLE 5 CURRENT HEALTH EXPENDITURE (% OF GDP) OF KEY COUNTRIES, 2018-2020
  • 5.6 TARIFF & REGULATORY LANDSCAPE
    • 5.6.1 REGULATIONS
      • 5.6.1.1 Europe
      • 5.6.1.2 US
      • 5.6.1.3 Others
    • 5.6.2 STANDARDS
      • 5.6.2.1 ISO 9001
      • 5.6.2.2 ISO 22000
      • 5.6.2.3 ASTM D3475
      • 5.6.2.4 USP (United States Pharmacopeia) Standards
      • 5.6.2.5 Child-resistant Packaging Standards
    • 5.6.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.7 TECHNOLOGY ANALYSIS
    • 5.7.1 NANOTECHNOLOGY
    • 5.7.2 PACKAGING FOR BIOLOGICS
    • 5.7.3 SMART PACKAGING
    • 5.7.4 ANTI-COUNTERFEIT PACKAGING
    • 5.7.5 OTHER SMART TRENDS AND TECHNOLOGIES
  • 5.8 PRICING ANALYSIS
    • 5.8.1 AVERAGE SELLING PRICE, BY REGION
    • FIGURE 22 AVERAGE SELLING PRICE, BY REGION (USD/KG)
    • 5.8.2 AVERAGE SELLING PRICE, BY RAW MATERIAL
    • TABLE 7 AVERAGE SELLING PRICE, BY RAW MATERIAL (USD/KG)
  • 5.9 ECOSYSTEM/MARKET MAP
    • FIGURE 23 PHARMACEUTICAL PACKAGING MARKET: ECOSYSTEM MAPPING
    • TABLE 8 PHARMACEUTICAL PACKAGING MARKET: ROLE IN ECOSYSTEM
  • 5.10 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
    • FIGURE 24 SUSTAINABLE PACKAGING, IOT, AND NANOTECHNOLOGY TO DRIVE FUTURE GROWTH
  • 5.11 PATENT ANALYSIS
    • 5.11.1 INTRODUCTION
    • 5.11.2 METHODOLOGY
    • 5.11.3 DOCUMENT TYPES
    • FIGURE 25 PATENTS REGISTERED (2012-2022)
    • 5.11.4 PUBLICATION TRENDS
    • FIGURE 26 NUMBER OF PATENTS IN LAST 10 YEARS, 2012-2022
    • 5.11.5 INSIGHTS
    • 5.11.6 JURISDICTION ANALYSIS
    • FIGURE 27 TOP JURISDICTIONS
    • 5.11.7 TOP APPLICANTS
    • FIGURE 28 TOP 10 PATENT APPLICANTS
    • TABLE 9 PATENTS BY SANOFI
    • TABLE 10 PATENTS BY SCHOTT AG
    • TABLE 11 PATENTS BY NOVARTIS AG
    • FIGURE 29 TOP 10 PATENT OWNERS
    • TABLE 12 TOP 10 PATENT OWNERS IN LAST 10 YEARS
  • 5.12 RAW MATERIAL ANALYSIS
    • 5.12.1 PLASTICS
    • 5.12.2 PAPER
    • 5.12.3 GLASS
    • 5.12.4 METALS
  • 5.13 TRADE ANALYSIS
    • 5.13.1 IMPORT SCENARIO
    • TABLE 13 REGION-WISE IMPORT TRADE (USD MILLION)
    • FIGURE 30 REGION-WISE IMPORT TRADE (USD MILLION)
    • 5.13.2 EXPORT SCENARIO
    • TABLE 14 REGION-WISE EXPORT TRADE (USD MILLION)
    • FIGURE 31 REGION-WISE EXPORT TRADE (USD MILLION)
  • 5.14 KEY CONFERENCES & EVENTS IN 2024-2025
    • TABLE 15 KEY CONFERENCES & EVENTS IN 2023-2024
  • 5.15 CASE STUDY ANALYSIS
    • 5.15.1 MOISTURE BARRIER TECHNOLOGY FOR EFFICIENT DRUG DELIVERY
    • 5.15.2 CUSTOM METERING VALVE FOR INHALERS
  • 5.16 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE DRUG DELIVERY MODES
    • 5.16.2 BUYING CRITERIA
      • 5.16.2.1 Quality
      • 5.16.2.2 Service
    • FIGURE 32 SUPPLIER SELECTION CRITERION

6 PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE

  • 6.1 INTRODUCTION
    • FIGURE 33 PRIMARY PACKAGING TO ACCOUNT FOR LARGER SHARE DURING FORECAST PERIOD
    • TABLE 17 PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020-2022 (USD MILLION)
    • TABLE 18 PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023-2028 (USD MILLION)
  • 6.2 PRIMARY
    • 6.2.1 INNOVATIVE PACKAGING SOLUTIONS FOR DRUG DELIVERY SYSTEMS TO DRIVE MARKET
  • 6.3 SECONDARY
    • 6.3.1 RISING ADOPTION OF PREFILLED CONTAINERS AND DELIVERY DEVICES TO FUEL DEMAND

7 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL

  • 7.1 INTRODUCTION
    • FIGURE 34 PLASTICS TO DOMINATE MARKET DURING FORECAST PERIOD
    • TABLE 19 BASIC PACKAGING RAW MATERIALS USED IN PHARMACEUTICAL PACKAGING
    • TABLE 20 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020-2022 (KILOTON)
    • TABLE 21 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023-2028 (KILOTON)
    • TABLE 22 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020-2022 (USD MILLION)
    • TABLE 23 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023-2028 (USD MILLION)
  • 7.2 PLASTIC
    • 7.2.1 EFFECTIVE BARRIER PROPERTIES AND COST REDUCTION TO DRIVE MARKET
    • TABLE 24 PLASTICS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020-2022 (USD MILLION)
    • TABLE 25 PLASTICS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023-2028 (USD MILLION)
    • 7.2.2 HIGH-DENSITY POLYETHYLENE
    • 7.2.3 POLYESTER
    • 7.2.4 POLYPROPYLENE
    • 7.2.5 LOW-DENSITY POLYETHYLENE
    • 7.2.6 POLYVINYL CHLORIDE
    • 7.2.7 CYCLIC OLEFIN COPOLYMER
    • 7.2.8 POLYETHYLENE TEREPHTHALATE
  • 7.3 PAPER & PAPERBOARD
    • 7.3.1 INNOVATIONS IN SECONDARY PACKAGING TO PROPEL MARKET
    • TABLE 26 PAPER & PAPERBOARD: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020-2022 (USD MILLION)
    • TABLE 27 PAPER & PAPERBOARD: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 7.4 GLASS
    • 7.4.1 CHEMICAL RESISTANCE AND STURDINESS TO BOOST DEMAND
    • TABLE 28 GLASS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020-2022 (USD MILLION)
    • TABLE 29 GLASS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023-2028 (USD MILLION)
    • TABLE 30 GLASS PACKAGING TYPES
  • 7.5 METALS
    • 7.5.1 INCREASING USE OF ALUMINUM FOR BLISTER PACKAGING TO DRIVE MARKET
    • TABLE 31 METALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020-2022 (USD MILLION)
    • TABLE 32 METALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 7.6 OTHER RAW MATERIALS
    • TABLE 33 OTHER RAW MATERIALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020-2022 (USD MILLION)
    • TABLE 34 OTHER RAW MATERIALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023-2028 (USD MILLION)

8 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY

  • 8.1 INTRODUCTION
    • FIGURE 35 ORAL DRUG DELIVERY ACCOUNTED FOR LARGEST SHARE IN 2023
    • TABLE 35 DRUG DELIVERY: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020-2022 (USD MILLION)
    • TABLE 36 DRUG DELIVERY: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023-2028 (USD MILLION)
    • TABLE 37 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020-2022 (USD MILLION)
    • TABLE 38 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023-2028 (USD MILLION)
  • 8.2 ORAL
    • 8.2.1 ADOPTION OF NANOCARRIERS AND CYCLODEXTRINS TO FUEL MARKET
    • TABLE 39 ORAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020-2022 (USD MILLION)
    • TABLE 40 ORAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 8.3 PULMONARY
    • 8.3.1 INCREASING CASES OF LUNG DISORDERS TO DRIVE MARKET
    • TABLE 41 PULMONARY: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020-2022 (USD MILLION)
    • TABLE 42 PULMONARY: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 8.4 TRANSDERMAL
    • 8.4.1 SURGING DEMAND FOR PAINLESS DRUG DELIVERY AND SELF-ADMINISTRATION OF DRUGS TO FUEL MARKET
    • TABLE 43 TRANSDERMAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020-2022 (USD MILLION)
    • TABLE 44 TRANSDERMAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 8.5 INJECTABLE 119 8.5.1 INCREASING USE OF BIOLOGICS TO BOOST MARKET
    • TABLE 45 INJECTABLE: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020-2022 (USD MILLION)
    • TABLE 46 INJECTABLE: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 8.6 TOPICAL
    • 8.6.1 RISING PREVALENCE OF SKIN DISEASES TO BOOST DEMAND FOR TOPICAL DRUGS
    • TABLE 47 TOPICAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020-2022 (USD MILLION)
    • TABLE 48 TOPICAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 8.7 NASAL
    • 8.7.1 RAPID ABSORPTION AND QUICK ACTION TO FUEL DEMAND FOR NASAL DROPS
    • TABLE 49 NASAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020-2022 (USD MILLION)
    • TABLE 50 NASAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 8.8 OCULAR/OPHTHALMIC
    • 8.8.1 INCREASING FREQUENCY OF OPTHALMIC DISEASES TO DRIVE MARKET
    • TABLE 51 OCULAR/OPHTHALMIC: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020-2022 (USD MILLION)
    • TABLE 52 OCULAR/OPHTHALMIC: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 8.9 INTRAVENOUS
    • 8.9.1 HIGH OCCURENCE OF CHRONIC DISEASES TO FUEL MARKET
    • TABLE 53 INTRAVENOUS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020-2022 (USD MILLION)
    • TABLE 54 INTRAVENOUS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 8.10 OTHER DRUG DELIVERY MODES
    • TABLE 55 OTHER DRUG DELIVERY MODES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020-2022 (USD MILLION)
    • TABLE 56 OTHER DRUG DELIVERY MODES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023-2028 (USD MILLION)

9 PHARMACEUTICAL PACKAGING MARKET, BY TYPE

  • 9.1 INTRODUCTION
    • FIGURE 36 PLASTIC BOTTLES TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD
    • TABLE 57 PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020-2022 (USD MILLION)
    • TABLE 58 PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023-2028 (USD MILLION)
  • 9.2 PLASTIC BOTTLES
    • 9.2.1 EXTENSIVE USE IN PACKAGING ORAL DRUGS TO BOOST MARKET
    • TABLE 59 PLASTIC BOTTLES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020-2022 (USD MILLION)
    • TABLE 60 PLASTIC BOTTLES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023-2028 (USD MILLION)
    • 9.2.2 STANDARD PLASTIC BOTTLES
    • 9.2.3 PLASTIC DISPENSING BOTTLES
    • 9.2.4 PLASTIC JARS
  • 9.3 BLISTER PACKS
    • 9.3.1 ANTIMICROBIAL RESISTANCE AND TAMPER-EVIDENT FEATURES TO DRIVE MARKET
    • TABLE 61 BLISTER PACKS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020-2022 (USD MILLION)
    • TABLE 62 BLISTER PACKS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023-2028 (USD MILLION)
    • 9.3.2 COMPARTMENT PACKS
    • 9.3.3 WALLET PACKS
  • 9.4 LABELS & ACCESSORIES
    • 9.4.1 NEED FOR STRINGENT GUIDELINES ON DRUG INSTRUCTIONS TO FUEL DEMAND
    • TABLE 63 LABELS & ACCESSORIES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020-2022 (USD MILLION)
    • TABLE 64 LABELS & ACCESSORIES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023-2028 (USD MILLION)
    • 9.4.2 SELF ADHESIVE
    • 9.4.3 DIE CUT
    • 9.4.4 HOLOGRAPHIC STRIPS
    • 9.4.5 TAMPER PROOF
    • 9.4.6 OTHER LABELS
  • 9.5 CAPS & CLOSURES
    • 9.5.1 DEMAND FOR CHILD-RESISTANT AND TAMPER-EVIDENT PACKAGING TO FUEL MARKET
    • TABLE 65 CAPS & CLOSURES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020-2022 (USD MILLION)
    • TABLE 66 CAPS & CLOSURES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 9.6 MEDICAL SPECIALTY BAGS
    • 9.6.1 INCREASING PREVALENCE OF CHRONIC DISEASES TO DRIVE DEMAND
    • TABLE 67 MEDICAL SPECIALTY BAGS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020-2022 (USD MILLION)
    • TABLE 68 MEDICAL SPECIALTY: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 9.7 PREFILLED SYRINGES
    • 9.7.1 RISING NEED FOR HIGH-QUALITY DRUG DELIVERY SYSTEMS TO BOOST MARKET
    • TABLE 69 PREFILLED SYRINGES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020-2022 (USD MILLION)
    • TABLE 70 PREFILLED SYRINGES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 9.8 TEMPERATURE-CONTROLLED PACKAGING
    • 9.8.1 SURGING DEMAND FOR TEMPERATURE-SENSITIVE DRUGS AND VACCINES TO FUEL MARKET
    • TABLE 71 TEMPERATURE-CONTROLLED PACKAGING: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020-2022 (USD MILLION)
    • TABLE 72 TEMPERATURE-CONTROLLED PACKAGING: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 9.9 POUCHES & STRIP PACKS
    • 9.9.1 INCREASING DEMAND FOR COST-EFFECTIVE SOLUTIONS TO DRIVE MARKET
    • TABLE 73 POUCHES & STRIP PACKS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020-2022 (USD MILLION)
    • TABLE 74 POUCHES & STRIP PACKS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 9.10 AMPOULES
    • 9.10.1 HIGH REQUIREMENT FOR SMALL DOSAGE SOLUTIONS TO DRIVE MARKET
    • TABLE 75 AMPOULES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020-2022 (USD MILLION)
    • TABLE 76 AMPOULES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 9.11 VIALS
    • 9.11.1 CONSISTENT DEMAND FOR VIALS IN VACCINE PACKAGING TO DRIVE MARKET
    • TABLE 77 VIALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020-2022 (USD MILLION)
    • TABLE 78 VIALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 9.12 PREFILLED INHALERS
    • 9.12.1 HIGH DEMAND FOR CONVENIENT AND ECO-FRIENDLY PACKAGING TO DRIVE MARKET
    • TABLE 79 PREFILLED INHALERS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020-2022 (USD MILLION)
    • TABLE 80 PREFILLED INHALERS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023-2028 (USD MILLION)
    • 9.12.2 METERED DOSE INHALERS
    • 9.12.3 DRY POWDER INHALERS
  • 9.13 MEDICATION TUBES
    • 9.13.1 INCREASING DEMAND IN CURING SKIN AILMENTS TO DRIVE MARKET
    • TABLE 81 MEDICATION TUBES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020-2022 (USD MILLION)
    • TABLE 82 MEDICATION TUBES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023-2028 (USD MILLION)
    • 9.13.2 COMPOSITE TUBES
    • 9.13.3 ALL-PLASTIC TUBES
    • 9.13.4 COLLAPSIBLE METAL TUBES
  • 9.14 JARS & CANISTERS
    • 9.14.1 EFFECTIVE BARRIER PROPERTIES TO FUEL DEMAND FOR DESICCANT CANISTERS
    • TABLE 83 JARS & CANISTERS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020-2022 (USD MILLION)
    • TABLE 84 JARS & CANISTERS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 9.15 CARTRIDGES
    • 9.15.1 INCREASED USE IN CHRONIC DISEASES TO DRIVE MARKET
    • TABLE 85 CARTRIDGES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020-2022 (USD MILLION)
    • TABLE 86 CARTRIDGES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 9.16 OTHER TYPES
    • TABLE 87 OTHER TYPES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020-2022 (USD MILLION)
    • TABLE 88 OTHER TYPES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023-2028 (USD MILLION)

10 PHARMACEUTICAL PACKAGING MARKET, BY REGION

  • 10.1 INTRODUCTION
    • FIGURE 37 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
    • TABLE 89 PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020-2022 (USD MILLION)
    • TABLE 90 PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 10.2 NORTH AMERICA
    • 10.2.1 RECESSION IMPACT
    • FIGURE 38 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SNAPSHOT
    • TABLE 91 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020-2022 (USD MILLION)
    • TABLE 92 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 93 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020-2022 (USD MILLION)
    • TABLE 94 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023-2028 (USD MILLION)
    • TABLE 95 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020-2022 (USD MILLION)
    • TABLE 96 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023-2028 (USD MILLION)
    • TABLE 97 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020-2022 (USD MILLION)
    • TABLE 98 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023-2028 (USD MILLION)
    • TABLE 99 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020-2022 (USD MILLION)
    • TABLE 100 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023-2028 (USD MILLION)
    • TABLE 101 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020-2022 (KILOTON)
    • TABLE 102 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023-2028 (KILOTON)
    • 10.2.2 US
      • 10.2.2.1 Rapid technological advancements in pharmaceutical packaging to drive market
    • TABLE 103 US: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020-2022 (USD MILLION)
    • TABLE 104 US: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023-2028 (USD MILLION)
    • 10.2.3 CANADA
      • 10.2.3.1 Competitive business environment to boost market
    • TABLE 105 CANADA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020-2022 (USD MILLION)
    • TABLE 106 CANADA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023-2028 (USD MILLION)
    • 10.2.4 MEXICO
      • 10.2.4.1 Government initiatives in healthcare industry to fuel demand for pharmaceutical products
    • TABLE 107 MEXICO: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020-2022 (USD MILLION)
    • TABLE 108 MEXICO: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023-2028 (USD MILLION)
  • 10.3 EUROPE
    • 10.3.1 RECESSION IMPACT
    • FIGURE 39 EUROPE: PHARMACEUTICAL PACKAGING MARKET SNAPSHOT
    • TABLE 109 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020-2022 (USD MILLION)
    • TABLE 110 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 111 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020-2022 (USD MILLION)
    • TABLE 112 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023-2028 (USD MILLION)
    • TABLE 113 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020-2022 (USD MILLION)
    • TABLE 114 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023-2028 (USD MILLION)
    • TABLE 115 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020-2022 (USD MILLION)
    • TABLE 116 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023-2028 (USD MILLION)
    • TABLE 117 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020-2022 (USD MILLION)
    • TABLE 118 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023-2028 (USD MILLION)
    • TABLE 119 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020-2022 (KILOTON)
    • TABLE 120 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023-2028 (KILOTON)
    • 10.3.2 GERMANY
      • 10.3.2.1 Increase in aging population and noncommunicable diseases to drive market
    • TABLE 121 GERMANY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020-2022 (USD MILLION)
    • TABLE 122 GERMANY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023-2028 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 High demand for generic drugs to drive market
    • TABLE 123 FRANCE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020-2022 (USD MILLION)
    • TABLE 124 FRANCE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023-2028 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Rising exports of pharmaceutical products to boost market
    • TABLE 125 ITALY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020-2022 (USD MILLION)
    • TABLE 126 ITALY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023-2028 (USD MILLION)
    • 10.3.5 UK
      • 10.3.5.1 Innovations in drug manufacturing to drive market
    • TABLE 127 UK: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020-2022 (USD MILLION)
    • TABLE 128 UK: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023-2028 (USD MILLION)
    • 10.3.6 SPAIN
      • 10.3.6.1 Government initiatives in healthcare sector to boost demand
    • TABLE 129 SPAIN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020-2022 (USD MILLION)
    • TABLE 130 SPAIN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023-2028 (USD MILLION)
    • 10.3.7 RUSSIA
      • 10.3.7.1 Government initiatives for domestic production of pharmaceuticals to fuel market
    • TABLE 131 RUSSIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020-2022 (USD MILLION)
    • TABLE 132 RUSSIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023-2028 (USD MILLION)
    • 10.3.8 REST OF EUROPE
    • TABLE 133 REST OF EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020-2022 (USD MILLION)
    • TABLE 134 REST OF EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023-2028 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • 10.4.1 RECESSION IMPACT
    • FIGURE 40 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SNAPSHOT
    • TABLE 135 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020-2022 (USD MILLION)
    • TABLE 136 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 137 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020-2022 (USD MILLION)
    • TABLE 138 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023-2028 (USD MILLION)
    • TABLE 139 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020-2022 (USD MILLION)
    • TABLE 140 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023-2028 (USD MILLION)
    • TABLE 141 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020-2022 (USD MILLION)
    • TABLE 142 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023-2028 (USD MILLION)
    • TABLE 143 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020-2022 (USD MILLION)
    • TABLE 144 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023-2028 (USD MILLION)
    • TABLE 145 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020-2022 (KILOTON)
    • TABLE 146 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023-2028 (KILOTON)
    • 10.4.2 CHINA
      • 10.4.2.1 Increased investments in biologics and biosimilar drug research to drive market
    • TABLE 147 CHINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020-2022 (USD MILLION)
    • TABLE 148 CHINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023-2028 (USD MILLION)
    • 10.4.3 JAPAN
      • 10.4.3.1 Rise in aging population to drive demand for medications
    • TABLE 149 JAPAN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020-2022 (USD MILLION)
    • TABLE 150 JAPAN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023-2028 (USD MILLION)
    • 10.4.4 SOUTH KOREA
      • 10.4.4.1 Well-developed healthcare industry and presence of major pharmaceuticals manufacturers to drive market
    • TABLE 151 SOUTH KOREA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020-2022 (USD MILLION)
    • TABLE 152 SOUTH KOREA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023-2028 (USD MILLION)
    • 10.4.5 INDIA
      • 10.4.5.1 Large domestic consumption and export of generic drugs to drive market
    • TABLE 153 INDIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020-2022 (USD MILLION)
    • TABLE 154 INDIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023-2028 (USD MILLION)
    • 10.4.6 AUSTRALIA
      • 10.4.6.1 Wide adoption of Medicare and PBS schemes to drive market
    • TABLE 155 AUSTRALIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020-2022 (USD MILLION)
    • TABLE 156 AUSTRALIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023-2028 (USD MILLION)
    • 10.4.7 REST OF ASIA PACIFIC
    • TABLE 157 REST OF ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020-2022 (USD MILLION)
    • TABLE 158 REST OF ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023-2028 (USD MILLION)
  • 10.5 SOUTH AMERICA
    • 10.5.1 RECESSION IMPACT
    • TABLE 159 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020-2022 (USD MILLION)
    • TABLE 160 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 161 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020-2022 (USD MILLION)
    • TABLE 162 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023-2028 (USD MILLION)
    • TABLE 163 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020-2022 (USD MILLION)
    • TABLE 164 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023-2028 (USD MILLION)
    • TABLE 165 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020-2022 (USD MILLION)
    • TABLE 166 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023-2028 (USD MILLION)
    • TABLE 167 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020-2022 (USD MILLION)
    • TABLE 168 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023-2028 (USD MILLION)
    • TABLE 169 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020-2022 (KILOTON)
    • TABLE 170 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023-2028 (KILOTON)
    • 10.5.2 BRAZIL
      • 10.5.2.1 Free and universal healthcare services to boost market
    • TABLE 171 BRAZIL: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020-2022 (USD MILLION)
    • TABLE 172 BRAZIL: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023-2028 (USD MILLION)
    • 10.5.3 ARGENTINA
      • 10.5.3.1 Rapid urbanization and increase in import of drugs to fuel market
    • TABLE 173 ARGENTINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020-2022 (USD MILLION)
    • TABLE 174 ARGENTINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023-2028 (USD MILLION)
    • 10.5.4 REST OF SOUTH AMERICA
    • TABLE 175 REST OF SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020-2022 (USD MILLION)
    • TABLE 176 REST OF SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023-2028 (USD MILLION)
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 RECESSION IMPACT
    • TABLE 177 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020-2022 (USD MILLION)
    • TABLE 178 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 179 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020-2022 (USD MILLION)
    • TABLE 180 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023-2028 (USD MILLION)
    • TABLE 181 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020-2022 (USD MILLION)
    • TABLE 182 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023-2028 (USD MILLION)
    • TABLE 183 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020-2022 (USD MILLION)
    • TABLE 184 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023-2028 (USD MILLION)
    • TABLE 185 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020-2022 (USD MILLION)
    • TABLE 186 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023-2028 (USD MILLION)
    • TABLE 187 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020-2022 (KILOTON)
    • TABLE 188 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023-2028 (KILOTON)
    • 10.6.2 GCC
      • 10.6.2.1 UAE
        • 10.6.2.1.1 Increasing initiatives for domestic pharmaceutical production to drive market
    • TABLE 189 UAE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020-2022 (USD MILLION)
    • TABLE 190 UAE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023-2028 (USD MILLION)
      • 10.6.2.2 Saudi Arabia
        • 10.6.2.2.1 More comprehensive access to healthcare services to fuel demand for pharmaceuticals
    • TABLE 191 SAUDI ARABIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020-2022 (USD MILLION)
    • TABLE 192 SAUDI ARABIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023-2028 (USD MILLION)
      • 10.6.2.3 Rest of GCC
    • 10.6.3 SOUTH AFRICA
      • 10.6.3.1 Gradual rise in use of generic drugs to drive market
    • TABLE 193 SOUTH AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020-2022 (USD MILLION)
    • TABLE 194 SOUTH AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023-2028 (USD MILLION)
    • 10.6.4 REST OF MIDDLE EAST & AFRICA
    • TABLE 195 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020-2022 (USD MILLION)
    • TABLE 196 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023-2028 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN
    • FIGURE 41 OVERVIEW OF KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS BETWEEN 2019 AND 2023
  • 11.3 REVENUE ANALYSIS
    • FIGURE 42 REVENUE ANALYSIS OF KEY COMPANIES (2020-2022)
  • 11.4 MARKET SHARE ANALYSIS
    • 11.4.1 RANKING ANALYSIS OF KEY MARKET PLAYERS, 2022
    • FIGURE 43 RANKING OF TOP 5 PLAYERS IN PHARMACEUTICAL PACKAGING MARKET, 2022
    • 11.4.2 MARKET SHARE OF KEY PLAYERS, 2022
    • FIGURE 44 PHARMACEUTICAL PACKAGING MARKET SHARE, BY COMPANY (2022)
    • TABLE 197 PHARMACEUTICAL PACKAGING MARKET: DEGREE OF COMPETITION
  • 11.5 COMPANY EVALUATION MATRIX
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • FIGURE 45 PHARMACEUTICAL PACKAGING MARKET: COMPANY EVALUATION MATRIX, 2022
    • 11.5.5 COMPANY FOOTPRINT
    • TABLE 198 PACKAGING TYPE FOOTPRINT (25 COMPANIES)
    • TABLE 199 DRUG DELIVERY MODE FOOTPRINT (25 COMPANIES)
    • TABLE 200 REGION FOOTPRINT (25 COMPANIES)
    • TABLE 201 OVERALL COMPANY FOOTPRINT (25 COMPANIES)
  • 11.6 START-UP/SME EVALUATION MATRIX
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 RESPONSIVE COMPANIES
    • 11.6.3 DYNAMIC COMPANIES
    • 11.6.4 STARTING BLOCKS
    • FIGURE 46 PHARMACEUTICAL PACKAGING MARKET: START-UP/SME EVALUATION MATRIX, 2022
    • 11.6.5 COMPETITIVE BENCHMARKING
    • TABLE 202 PHARMACEUTICAL PACKAGING MARKET: LIST OF COMPANIES (25 COMPANIES)
  • 11.7 COMPETITIVE SCENARIO AND TRENDS
    • 11.7.1 PRODUCT LAUNCHES/DEVELOPMENTS
    • TABLE 203 PHARMACEUTICAL PACKAGING MARKET: PRODUCT LAUNCHES/ DEVELOPMENTS, 2019-2023
    • 11.7.2 DEALS
    • TABLE 204 PHARMACEUTICAL PACKAGING MARKET: DEALS, 2019-2023
    • 11.7.3 OTHER DEVELOPMENTS
    • TABLE 205 PHARMACEUTICAL PACKAGING MARKET: OTHER DEVELOPMENTS, 2019-2023

12 COMPANY PROFILES

(Business overview, Products/Solutions/Services offered, Recent Developments, MnM view, Right to win, Strategic choices, Weaknesses and competitive threats) **

  • 12.1 KEY PLAYERS
    • 12.1.1 BERRY GLOBAL INC.
    • TABLE 206 BERRY GLOBAL INC.: COMPANY OVERVIEW
    • FIGURE 47 BERRY GLOBAL INC.: COMPANY SNAPSHOT
    • TABLE 207 BERRY GLOBAL INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 208 BERRY GLOBAL INC.: PRODUCT LAUNCHES
    • TABLE 209 BERRY GLOBAL INC.: DEALS
    • TABLE 210 BERRY GLOBAL INC.: OTHER DEVELOPMENTS
    • 12.1.2 GERRESHEIMER AG
    • TABLE 211 GERRESHEIMER AG: COMPANY OVERVIEW
    • FIGURE 48 GERRESHEIMER AG: COMPANY SNAPSHOT
    • TABLE 212 GERRESHEIMER AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 213 GERRESHEIMER AG: PRODUCT LAUNCHES
    • TABLE 214 GERRESHEIMER AG: DEALS
    • TABLE 215 GERRESHEIMER AG: OTHER DEVELOPMENTS
    • 12.1.3 AMCOR PLC
    • TABLE 216 AMCOR PLC: COMPANY OVERVIEW
    • FIGURE 49 AMCOR PLC: COMPANY SNAPSHOT
    • TABLE 217 AMCOR PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 218 AMCOR PLC: PRODUCT LAUNCHES
    • TABLE 219 AMCOR PLC: DEALS
    • TABLE 220 AMCOR PLC: OTHER DEVELOPMENTS
    • 12.1.4 SCHOTT AG
    • TABLE 221 SCHOTT AG: COMPANY OVERVIEW
    • FIGURE 50 SCHOTT AG: COMPANY SNAPSHOT
    • TABLE 222 SCHOTT AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 223 SCHOTT AG: PRODUCT LAUNCHES
    • TABLE 224 SCHOTT AG: DEALS
    • TABLE 225 SCHOTT AG: OTHER DEVELOPMENTS
    • 12.1.5 APTARGROUP, INC.
    • TABLE 226 APTARGROUP, INC.: COMPANY OVERVIEW
    • FIGURE 51 APTARGROUP, INC.: COMPANY SNAPSHOT
    • TABLE 227 APTARGROUP, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 228 APTARGROUP, INC.: PRODUCT LAUNCHES
    • TABLE 229 APTARGROUP, INC.: DEALS
    • TABLE 230 APTARGROUP, INC.: OTHER DEVELOPMENTS
    • 12.1.6 BD
    • TABLE 231 BD: COMPANY OVERVIEW
    • FIGURE 52 BD: COMPANY SNAPSHOT
    • TABLE 232 BD: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 233 BD: PRODUCT LAUNCHES
    • TABLE 234 BD: DEALS
    • TABLE 235 BD: OTHER DEVELOPMENTS
    • 12.1.7 WESTROCK COMPANY
    • TABLE 236 WESTROCK COMPANY: COMPANY OVERVIEW
    • FIGURE 53 WESTROCK COMPANY: COMPANY SNAPSHOT
    • TABLE 237 WESTROCK COMPANY: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 238 WESTROCK COMPANY: DEALS
    • TABLE 239 WESTROCK COMPANY: OTHER DEVELOPMENTS
    • 12.1.8 NIPRO CORPORATION
    • TABLE 240 NIPRO CORPORATION: COMPANY OVERVIEW
    • FIGURE 54 NIPRO CORPORATION: COMPANY SNAPSHOT
    • TABLE 241 NIPRO CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 242 NIPRO CORPORATION: PRODUCT LAUNCHES
    • TABLE 243 NIPRO CORPORATION: DEALS
    • 12.1.9 CATALENT, INC.
    • TABLE 244 CATALENT, INC.: COMPANY OVERVIEW
    • FIGURE 55 CATALENT, INC.: COMPANY SNAPSHOT
    • TABLE 245 CATALENT, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 246 CATALENT, INC.: DEALS
    • TABLE 247 CATALENT, INC.: OTHER DEVELOPMENTS
    • 12.1.10 SEALED AIR
    • TABLE 248 SEALED AIR: COMPANY OVERVIEW
    • FIGURE 56 SEALED AIR: COMPANY SNAPSHOT
    • TABLE 249 SEALED AIR: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 250 SEALED AIR: PRODUCT LAUNCHES
    • TABLE 251 SEALED AIR: DEALS
    • 12.1.11 WEST PHARMACEUTICAL SERVICES, INC.
    • TABLE 252 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY OVERVIEW
    • FIGURE 57 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT
    • TABLE 253 WEST PHARMACEUTICAL SERVICES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 254 WEST PHARMACEUTICAL SERVICES, INC.: PRODUCT LAUNCHES
    • TABLE 255 WEST PHARMACEUTICAL SERVICES, INC.: OTHER DEVELOPMENTS
  • *Details on Business overview, Products/Solutions/Services offered, Recent Developments, MnM view, Right to win, Strategic choices, Weaknesses and competitive threats might not be captured in case of unlisted companies.
  • 12.2 OTHER PLAYERS
    • 12.2.1 ALPLA
    • TABLE 256 ALPLA: COMPANY OVERVIEW
    • 12.2.2 ARDAGH GROUP S.A.
    • TABLE 257 ARDAGH GROUP S.A.: COMPANY OVERVIEW
    • 12.2.3 CCL INDUSTRIES INC.
    • TABLE 258 CCL INDUSTRIES INC.: COMPANY OVERVIEW
    • 12.2.4 FRANK NOE
    • TABLE 259 FRANK NOE: COMPANY OVERVIEW
    • 12.2.5 GAPLAST GMBH
    • TABLE 260 GAPLAST GMBH: COMPANY OVERVIEW
    • 12.2.6 LONZA
    • TABLE 261 LONZA: COMPANY OVERVIEW
    • 12.2.7 MONDI GROUP
    • TABLE 262 MONDI GROUP: COMPANY OVERVIEW
    • 12.2.8 NOLATO AB
    • TABLE 263 NOLATO AB: COMPANY OVERVIEW
    • 12.2.9 ORIGIN PHARMA PACKAGING
    • TABLE 264 ORIGIN PHARMA PACKAGING: COMPANY OVERVIEW
    • 12.2.10 COMAR
    • TABLE 265 COMAR: COMPANY OVERVIEW
    • 12.2.11 BILCARE LIMITED
    • TABLE 266 BILCARE LIMITED: COMPANY OVERVIEW
    • 12.2.12 SGD PHARMA
    • TABLE 267 SGD PHARMA: COMPANY OVERVIEW
    • 12.2.13 SILGAN HOLDINGS INC.
    • TABLE 268 SILGAN HOLDINGS INC.: COMPANY OVERVIEW
    • 12.2.14 VETTER PHARMA INTERNATIONAL GMBH
    • TABLE 269 VETTER PHARMA INTERNATIONAL GMBH: COMPANY OVERVIEW

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS